Mogamulizumab-Induced Alopecia: Multicentric Case Series - Clinical, Trichoscopic, and Histological Characterization
February 2025
in “
Journal of the European Academy of Dermatology and Venereology
”
Studysummary In this study, researchers found that mogamulizumab-associated rashes and alopecia are common in patients treated for mycosis fungoides and Sézary syndrome and may be linked with a good treatment response.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer